Form D · Biotechnology

PEEL Therapeutics, Inc

Salt Lake City, UT · CIK 0001719212

Offering snapshot reported Feb 5, 2019 · SEC filing

Reported sold
$9.25M
Offering amount: $10M
Investors reported
70
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 6, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$4.63M$9.25MOct 19, 2017: $5,620,000.00Oct 19, 2017Feb 5, 2019: $9,252,000.00Feb 5, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$5,620,000 → $9,252,000
  • Reported investors42 → 70

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 5, 2019Amendment$9,252,000$3,632,000vs Oct 19, 201770SEC filing
Oct 19, 2017Initial$5,620,000No comparison42SEC filing

Offering details

Securities
Debt
Exemptions
06c
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-297059

Source: Form D, filed Feb 5, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James Levison Executive
Joshua Schiffman Director, Executive
Avraham Schroeder Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1387 S Ambassador Way
Salt Lake City, UT, 84108